14159 capital (GP), LLC Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
14159 capital (GP), LLC in Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: Director
Holdings: 303,449 shares
Current Value: $18,446,665
Latest Transaction: Feb 04 2011
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of 14159 capital (GP), LLC in Seagen Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, SGEN, GEVA, NPRO, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 04 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 15.50 | 48,197 | 747,054 | 303,449 | 255.3 K to 303.4 K (+18.88 %) |
Jun 09 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 11.92 | 1,746 | 20,814 | 255,252 | 253.5 K to 255.3 K (+0.69 %) |
Jun 09 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 11.95 | 11,685 | 139,688 | 253,506 | 241.8 K to 253.5 K (+4.83 %) |
Jun 09 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 11.87 | 1,628 | 19,321 | 241,821 | 240.2 K to 241.8 K (+0.68 %) |
Jun 09 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 11.90 | 1,477 | 17,578 | 240,193 | 238.7 K to 240.2 K (+0.62 %) |
May 27 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 11.95 | 150 | 1,793 | 238,716 | 238.6 K to 238.7 K (+0.06 %) |
May 05 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.72 | 5,608 | 71,316 | 238,566 | 233 K to 238.6 K (+2.41 %) |
May 05 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.73 | 1,343 | 17,098 | 232,958 | 231.6 K to 233 K (+0.58 %) |
May 05 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.68 | 2,676 | 33,922 | 231,615 | 228.9 K to 231.6 K (+1.17 %) |
May 05 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.74 | 269 | 3,428 | 228,939 | 228.7 K to 228.9 K (+0.12 %) |
May 05 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.94 | 2,581 | 33,403 | 228,670 | 226.1 K to 228.7 K (+1.14 %) |
May 05 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.92 | 3,029 | 39,130 | 226,089 | 223.1 K to 226.1 K (+1.36 %) |
May 04 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.68 | 1,575 | 19,973 | 223,060 | 221.5 K to 223.1 K (+0.71 %) |
May 04 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.64 | 6,673 | 84,357 | 221,485 | 214.8 K to 221.5 K (+3.11 %) |
May 04 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 12.56 | 199 | 2,500 | 214,812 | 214.6 K to 214.8 K (+0.09 %) |
May 04 2010 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 10.75 | 43,134 | 463,691 | 214,613 | 171.5 K to 214.6 K (+25.15 %) |
May 20 2009 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 9.72 | 14,576 | 141,679 | 171,479 | 156.9 K to 171.5 K (+9.29 %) |
Mar 19 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 8.02 | 1,673 | 13,420 | 156,903 | 155.2 K to 156.9 K (+1.08 %) |
Mar 19 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 7.80 | 2,245 | 17,513 | 155,230 | 153 K to 155.2 K (+1.47 %) |
Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 8.06 | 1,249 | 10,061 | 152,985 | 151.7 K to 153 K (+0.82 %) |
Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 8.08 | 2,673 | 21,607 | 151,736 | 149.1 K to 151.7 K (+1.79 %) |
Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 7.93 | 1,219 | 9,661 | 149,063 | 147.8 K to 149.1 K (+0.82 %) |
Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 7.98 | 362 | 2,889 | 147,844 | 147.5 K to 147.8 K (+0.25 %) |
Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 9.06 | 1,212 | 10,975 | 147,482 | 146.3 K to 147.5 K (+0.83 %) |
Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 8.94 | 49 | 438 | 146,270 | 146.2 K to 146.3 K (+0.03 %) |
Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 9.00 | 2,803 | 25,234 | 146,221 | 143.4 K to 146.2 K (+1.95 %) |
Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 9.00 | 819 | 7,371 | 143,418 | 142.6 K to 143.4 K (+0.57 %) |
Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 9.03 | 3,045 | 27,490 | 142,599 | 139.6 K to 142.6 K (+2.18 %) |
Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 8.78 | 2,084 | 18,292 | 139,554 | 137.5 K to 139.6 K (+1.52 %) |
Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 9.00 | 61,872 | 556,848 | 137,470 | 75.6 K to 137.5 K (+81.84 %) |
Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Sell | S | 8.72 | 19,561 | 170,572 | 75,598 | 95.2 K to 75.6 K (-20.56 %) |
Page: 1